Tequin (gatifloxacin), a new broad-spectrum quinolone
April 2001
Bristol-Myers Squibb is now marketing Tequin (gatifloxacin), a new broad-spectrum quinolone...similar to Avelox and Levaquin.
All three are approved for community-acquired pneumonia...sinusitis...and acute exacerbations of chronic bronchitis.
Tequin will also be used for UTIs and uncomplicated gonorrhea.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive